Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Business News Health & Science Biotechnology
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags Danone SA Food and drink Business
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Tags Science Business Pharmaceuticals
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Viking Therapeutics Inc
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Amgen Inc
From CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
Tags Novo Nordisk A/S ETF Edge Investment strategy
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Tags Pharmaceuticals Business Social issues
From CNBC.com News
Cramer's Lighting Round: Arm is a buy
Tags Stock Picks Market Outlook Arm Holdings PLC
From CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
Tags Pharmaceuticals Business Biotechnology
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags Microsoft Corp Viking Therapeutics Inc Alphabet Inc
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Eli Lilly and Co Health care industry CVS Health Corp
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags Madrigal Pharmaceuticals Inc Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Obesity Pharmaceuticals Health & Science
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags Health care industry Eli Lilly and Co Exchange/traded funds
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Health & Science Business News Companies
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags Eaton Corporation PLC Mad Money Compagnie Financiere Richemont SA
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Social issues Breaking News: Business Novo Nordisk A/S
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags US: News Companies Biotechnology
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Tesla Inc Markets Novo Nordisk A/S
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags Health care industry Eli Lilly and Co Investment strategy
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Health care industry Eli Lilly and Co Biotech and Pharmaceuticals
From CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
Tags Investing Business News U/S/ Markets
From CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Tags Breaking news Business Pharmaceuticals
From CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
Tags Novo Nordisk A/S Europe News Economic events
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Politics Markets Investment strategy
From CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
Tags Economic events Market Outlook Markets
From CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
Tags Daily Open Eli Lilly and Co Alphabet Inc
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Health & Science Weight loss diets Weight management
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.